Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 3;9(2):e70105.
doi: 10.1002/jgh3.70105. eCollection 2025 Feb.

Causal Exposures in Pancreatic Cancer Incidence: Insights From Mendelian Randomization Studies

Ashraf Mohamadkhani  1 , Reza Ghanbari  2 , Ramin Shakeri  3 , Mohammad Ali Mohammadkhani  4 , Akram Pourshams  1   3
Affiliations
Review

Causal Exposures in Pancreatic Cancer Incidence: Insights From Mendelian Randomization Studies

Ashraf Mohamadkhani et al. JGH Open. .

Abstract

Aim: Pancreatic cancer, marked by its high lethality and poor 5-year survival rate, requires a thorough understanding of its risk factors and etiological mechanisms. In this review, we collected the latest findings from Mendelian randomization (MR) studies to identify potential causal factors for pancreatic cancer.

Method and results: The present analysis encompasses MR studies on the gut and oral microbiomes, non-malignant phenotypes, blood metabolites, immune cells, and chronic inflammation. Specific gut and oral microbiome species have been identified as potential causal factors for pancreatic cancer, some with protective effects, and others increasing the risk. The review also highlights causal associations between obesity, type 2 diabetes, and pancreatic cancer, as well as the impact of blood metabolites and immune cell phenotypes on disease risk. Additionally, it investigates the causal effects of inflammatory bowel disease, showing a significant risk increase associated with Crohn's disease.

Conclusion: These insights emphasize the need for interdisciplinary research and personalized medicine to enhance prevention and treatment strategies for pancreatic cancer.

Keywords: Mendelian randomization; causal factors; pancreatic cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Principe D. R. and Rana A. J. C., “Updated Risk Factors to Inform Early Pancreatic Cancer Screening and Identify High Risk Patients,” Cancer Letters 485 (2020): 56–65. - PMC - PubMed
    1. Hu J.‐X., Zhao C.‐F., Chen W.‐B., et al., “Pancreatic Cancer: A Review of Epidemiology, Trend, and Risk Factors,” World Journal of Gastroenterology 27, no. 27 (2021): 4298. - PMC - PubMed
    1. Liu J., Mroczek M., Mach A., et al., “Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer,” Cancers 15, no. 3 (2023): 779. - PMC - PubMed
    1. Vogtmann E., Han Y., Caporaso J. G., et al., “Oral Microbial Community Composition Is Associated With Pancreatic Cancer: A Case‐Control Study in Iran,” Cancer Medicine 9, no. 2 (2020): 797–806. - PMC - PubMed
    1. Jiang Z., Mou Y., Wang H., et al., “Causal Effect Between Gut Microbiota and Pancreatic Cancer: A Two‐Sample Mendelian Randomization Study,” BMC Cancer 23, no. 1 (2023): 1091. - PMC - PubMed

LinkOut - more resources